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Abstract
3,4-methylenedioxymethamphetamine (MDMA), substance known as ”Ecstasy” among the people and used due
to entertainment, euphoric and energy booster effect, is one of the famous synthetic stimulants. 22-year-old man
was found as unconscious in the early morning. According to the expressions of his family and friends, it was
learned that he drank alcohol until late in the previous evening and took ecstasy besides this before he died. It
was reported that he was taken to intensive care unit with temperature of 41◦C and death occurred 12 hours later.
At autopsy in external examination, petechial and purpuric hemorrhages in purple and red color were detected
on body. In internal examination, petechial hemorrhages on the surface of the heart and lungs, subendocardial
hemorrhage in the heart, hemorrhage on the mucosal surface of the stomach were seen. In the toxicological
analyses of the blood, Paracetamol (4870 ng/ml), MDMA (847 ng/ml), MDA (94.2 ng/ml), Lidocaine (23 ng/ml),
Pantoprazole (10.5 ng/ml), Midazolam (1.83 ng/ml) were detected. The death occurred due to coagulopathy
related MDMA intoxication. Here, we present a case of autopsy, clinical findings and histopathologic findings,
laboratory results in medicolegal literature.
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Inroduction
3,4-methylenedioxymethamphetamine (MDMA),
which is also known as ”Ecstasy” among the peo-
ple and used due to entertainment, euphoric and
energy booster effect, is one of the popular syn-
thetic stimulants. After ingestion of an overdose, it
is known that tachycardia, hypertension, hyperther-
mia, rhabdomyolysis, brain edema and renal failure
are caused by the excessive sympathetic stimulation
[1]. Death cases related to hyperthermia and coag-
ulation were reported to taken of MDMA [2, 3].
Here, we report a case of the death occurred due to
coagulopathy related MDMA intoxication with au-
topsy, clinical findings and histopathologic findings,
laboratory results in medico legal literature.
1. Case Report
In our case, 22-year-old man was found as uncon-
scious in the early morning. According to the ex-
pressions of his family and friends, it was learned
that he drank alcohol until late in the previous
evening and took ecstasy besides this before he
died. It was reported that he was taken to inten-
sive care unit with temperature of 41◦C and death
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occurred 12 hours later. INR: 5.65 (0.85-1.15),
APTT: 116.1 sec (22.7-31.8), PT: 41.2 sec (10.8-
15) HGB: 6.73 g/dL (12.20-18.10), PLT: 15.1 K/µL
(142-424), Ethanol: 13.6 mg/dL (0.00-10.60), Cre-
atinine: 3.88 mg/dL (0.65-1.01), AST: 1664 IU/L
(13-28), ALT: 1585 IU/L (8-45), CK > 42670 IU/L
(47-240), Glucose: 21 mg/dL (70-100), Sodium
(Na): 155 mmol/L (136-145), LDH: > 4500IU/L
(125-243) were detected as laboratory findings. At
autopsy in external gross examination, petechial
and purpuric hemorrhages in purple and red color
were detected on the whole body. Bilateral perior-
bital ecchymosis especially prominent in left, pe-
techial and purpuric hemorrhages in dark purple and
red color on the back and both sides of the gluteal
region, purpuric hemorrhages 4×1 cm in length
on right sides of both upper and lower lips, 2.5×1
cm in length on left sides of both upper and lower
lips, 1.5×1 cm in length on left side of lower lip,
1 cm in length on right side of lower lip, large pur-
puric hemorrhages making invasion subcutaneous
tissue on medial upper sides of both arms, bleed-
ing 6×5 cm in length on right iliac and purpuric
hemorrhage 25×14 cm in length on the right upper
front of thigh were detected. In internal exami-
nation, purpuric hemorrhage under the scalp, pe-
techial hemorrhages on the surface of the heart and
lungs, subendocardial hemorrhage in the heart, hem-
orrhage on the mucosal surface of the stomach were
seen. In the toxicological analyses of the blood,
Paracetamol (4870 ng/ml), MDMA (847 ng/ml),
MDA (94.2 ng/ml), Lidocaine (23 ng/ml), Panto-
prazole (10.5 ng/ml), Midazolam (1.83 ng/ml) were
detected. It was recorded that death occurred due
to coagulopathy related MDMA intoxication.
2. Discussion
3,4-Methylenedioxymethamphetamine (MDMA) is
ring-substituted amphetamine derivative that is po-
tent CNS (Central Nervous System) stimulants and
structurally related to the hallucinogen mescaline
[4]. Its amphetamine-like characteristics produce ef-
fects such as tachycardia, hyperthermia, emotional
warmth, distortions in sensory and time perception
and sweating, whereas its quasi-hallucinogenic ef-
Figure 1. The purpuric hemorrhages under the
scalp.
fects are euphoria and a psychological ”high” [1, 4].
MDMA has a plasma half-life of 7.6 hour. Typi-
cally, after oral ingestion (75–150 mg), effects begin
within 1 hour and last 4–6 hour [5]. Many fatalities
have been reported with blood levels of MDMA 0.1–
2.1 mg liter [6]. However, a case of an overdose
of MDMA in which the blood level reached 4.3
mg liter with mild sinus tachycardia, somnolence
degree and no other clinical findings [7]. Henry
et al. reported that another overdose case which
blood level of MDMA was 7.72 mg liter, was the
highest recorded in a surviving patient, with just a
’hangover’, tachycardia and hypertension [6]. This
case shows a rare constellation of severe adverse
effects that can occur from MDMA: the ’syndrome’
of hyperpyrexia, multi-organ failure, and DIC (Dis-
seminated Intravascular Coagulation). A review
of literature showed only one other reported sur-
vival from MDMA associated serotonin syndrome
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with a temperature above 42.9◦C [8]. Hunter crite-
ria, serotonin syndrome is suggested if the patient
has taken a serotonergic agent and has one of the
four following cluster of symptoms/signs: a) spon-
taneous clonus, b) inducible clonus and agitation
or diaphoresis, c) ocular clonus and agitation or
diaphoresis, d) tremor and hyperreflexia, e) hyperto-
nia, hyperthermia (>38◦C or >100.4◦F) and ocular
or inducible clonus [9]. Our patient fit into cluster
’e’ above and also had coagulation.
The hyperthermia in serotonin syndrome is caused
by increased muscle activity and not from an alter-
ation in temperature regulation by the hypothala-
mus; antipyretic such as acetaminophen is not ef-
fective in the treatment [10]. Hyperthermia could
cause further side effects, such as rhabdomyoly-
sis, myoglobinuria, renal failure, liver damage, and
DIC [11]. The side effects were seen in our case.
Death is possible these adverse effects.
MDMA act on at least three neurotransmitter
pathways: the serotonergic (5-hydroxytryptamine)
pathway, the dopaminergic system, and the nora-
drenergic system. The serotonergic pathway is
mainly affected, which would account for the more
pronounced effect on mood. Serotonin plays a ma-
jor role in thermoregulation, and interference with
this mechanism is believed to be the cause of the
hyperthermia that arises as a complication of ring-
substituted amphetamine abuse. In addition, stim-
ulation of the noradrenergic system also probably
contributes to hyperthermia. Thus, hyperthermia
may account for many of the changes seen in deaths
from ring-substituted amphetamine abuse [12].
MDMA (also known as ecstasy) and ethanol
(alcohol) are two of the most commonly co-abused
substances [13]. According to the statement of
friends he abused alcohol, and MDMA. Blood level
of alcohol was 13.6 mg/dL. We think that blood al-
cohol level may decrease because of testing 6 hours
later after intake of alcohol. Alcohol use in rats al-
ters neurotransmission in the dopamine system [14],
and long-term MDMA use affects serotonergic neu-
rotransmission [15]. Drug-induced alterations in
monoaminergic neurotransmission systems that re-
ceived previously might have interacted with the
acute effects of the drugs [16].
Sano R et al. reported that myocardial fibro-
sis and calcification might have been caused by
repeated use of MDMA [11].
Here, we presented a case of autopsy, clinical
findings and histopathologic findings, laboratory
results in medicolegal literature.
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